Cancer Screenings: The Impacts of Early Detection Technology
Bispecific Antibody Treatment in Relapsed or Refractory Multiple Myeloma
Watch Expert Insights on Newly Diagnosed, Transplant-Ineligible Multiple Myeloma
Ken Shain, MD, PhD
PeerExamining Unmet Needs in Gastric and GEJ Cancer Care and the Role of Emergining Personalized Medicine
Nataliya Uboha, MD, PhD
PeerExperts Discuss What the TITAN Trial Means for Managing Patients With mCSPC
Improving Patient Care in SCLC: A Proactive Strategy from Dr. Kalmadi
Sujith Kalmadi, MD
PeerImproving Patient Care in SCLC: A Proactive Strategy from Dr. Porter
Jason Porter, MD
PeerAddressing Hesitancy on Biosimilars: From Development to Clinical Practice
Managing Anemia in Patients With Myelofibrosis
Ruben Mesa, MD, FACP, MPN Expert
PeerDurable Hct Control in Patients with Polycythemia Vera
Andrew Kuykendall, MD, MPN Expert
PeerSpleen Volume Reduction & Long-Term Survival in Myelofibrosis
Ruben Mesa, MD, FACP, MPN Expert
PeerComparing Targeted Therapies for Wild-Type RAS Metastatic Colorectal Cancer
Inflammation Biosimilars: Examining the Totality of Evidence for Approval